We are live on
!
Find out more
CDH
Charles D. Hyman Portfolio holdings
AUM
$1.79B
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
+3.15%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$783M
AUM Growth
+$29.5M
(+3.9%)
Cap. Flow
+$10.1M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
31.31%
Holding
161
New
15
Increased
53
Reduced
46
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$2.8M |
| 2 |
FRP Holdings
FRPH
|
+$2.31M |
| 3 |
Morgan Stanley Series A Preferred Stock
MS.PRA
|
+$1.62M |
| 4 |
RTX Corp
RTX
|
+$1.59M |
| 5 |
Microsoft
MSFT
|
+$1.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVER.PRA
EverBank Financial Corp.
EVER.PRA
|
+$9.34M |
| 2 |
Johnson Controls International
JCI
|
+$1.47M |
| 3 |
ConocoPhillips
COP
|
+$608K |
| 4 |
Bank of America
BAC
|
+$606K |
| 5 |
EVER
Everbank Financial Corp
EVER
|
+$507K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.46% |
| 2 | Consumer Staples | 10.6% |
| 3 | Financials | 10.29% |
| 4 | Healthcare | 9.57% |
| 5 | Consumer Discretionary | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Opko Health
OPK
$921M
| $119K | 0.02% |
18,119
| – | – |
|
|
NCV
152
Virtus Convertible & Income Fund
NCV
$374M
| $93K | 0.01% |
3,350
| – | – |
|
|
NVIV
153
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $81K | 0.01% |
2
| – | – |
|
|
SMRT
154
DELISTED
Stein Mart Inc
SMRT
| $54K | 0.01% |
+31,900
| New | +$63K |
|
|
GNMX
155
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $20K | ﹤0.01% |
15,143
| – | – |
|
|
156
Johnson Controls International
JCI
$87.5B
| – | – |
-34,936
| Closed | -$1.47M |
|
|
SONN
157
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
0
| – | -$16K |
|
158
Target
TGT
$62.1B
| – | – |
-3,800
| Closed | -$210K |
|
159
TotalEnergies
TTE
$193B
| – | – |
-4,000
| Closed | -$202K |
|
|
EVER
160
DELISTED
Everbank Financial Corp
EVER
| – | – |
-26,035
| Closed | -$507K |
|
|
EVER.PRA
161
DELISTED
EverBank Financial Corp.
EVER.PRA
| – | – |
-368,425
| Closed | -$9.34M |
|
Similar funds
AT
BPCA
HIG
H
LFDLE
PRIG
PO
GC
Charles D. Hyman's Q2 2017 Portfolio in Review
As of Q2 2017, Charles D. Hyman held 161 positions worth $783M, up 3.9% from $754M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Charles D. Hyman's Q2 2017 filing shows 15 new, 53 increased, 46 reduced and 5 closed positions. Its largest new stake was Occidental Petroleum: 15,360 shares worth $920K. The largest sale was EverBank Financial Corp., an estimated $9.34M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Financials.
- Charles D. Hyman's largest Q2 2017 buy was Occidental Petroleum: 15,360 shares worth $920K.
- Charles D. Hyman added most to Intel in Q2 2017, an estimated $2.8M increase.
- Charles D. Hyman's biggest Q2 2017 reduction was ConocoPhillips, cutting an estimated $608K.
- Charles D. Hyman fully exited EverBank Financial Corp. in Q2 2017, selling an estimated $9.34M.
- Charles D. Hyman's ten largest holdings make up 31% of its $783M portfolio in Q2 2017.
- Charles D. Hyman opened 15 new positions and closed 5 in Q2 2017.
- Charles D. Hyman's portfolio value rose 3.9% quarter-over-quarter to $783M.
Based on Charles D. Hyman's 13F filing for Q2 2017, filed 14 Aug 2017.